Search Results
Search for other papers by Patrick W. Owens in
Google Scholar
PubMed
Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom
Search for other papers by Terri P. McVeigh in
Google Scholar
PubMed
Search for other papers by Eoin J. Fahey in
Google Scholar
PubMed
Search for other papers by Marcia Bell in
Google Scholar
PubMed
Search for other papers by Denis S. Quill in
Google Scholar
PubMed
Search for other papers by Michael J. Kerin in
Google Scholar
PubMed
Search for other papers by Aoife J. Lowery in
Google Scholar
PubMed
, Plummer M, Dal Maso L: Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med 2016; 375: 614–617. 8 Shi RL, Qu N, Liao T, Wei WJ, Wang YL, Ji QH: The trend of age-group effect on prognosis in differentiated thyroid
Search for other papers by Nicholas S. Andresen in
Google Scholar
PubMed
Search for other papers by John M. Buatti in
Google Scholar
PubMed
Search for other papers by Hamed H. Tewfik in
Google Scholar
PubMed
Search for other papers by Nitin A. Pagedar in
Google Scholar
PubMed
Search for other papers by Carryn M. Anderson in
Google Scholar
PubMed
Search for other papers by John M. Watkins in
Google Scholar
PubMed
Introduction Thyroid cancer is the most frequently occurring endocrine cancer, with an increasing incidence noted in the US over the past 15 years [ 1 ]. Papillary and follicular histologic subtypes, known as “differentiated thyroid cancers
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Constance Xhaard in
Google Scholar
PubMed
Search for other papers by Juan J. Lence-Anta in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Yan Ren in
Google Scholar
PubMed
Rhône-Alpes Thyroid Cancer Registry, Cancer Research Center of Lyon (UMR INSERM 1052, CNRS 5286), RTH Laennec Faculty of Medicine, University of Lyon, Lyon
Search for other papers by Françoise Borson-Chazot in
Google Scholar
PubMed
Search for other papers by Geneviève Sassolas in
Google Scholar
PubMed
Search for other papers by Claire Schvartz in
Google Scholar
PubMed
Search for other papers by Marc Colonna in
Google Scholar
PubMed
French National Registry of Childhood Solid Tumours, CHU, Nancy
Search for other papers by Brigitte Lacour in
Google Scholar
PubMed
Search for other papers by Arlette Danzon in
Google Scholar
PubMed
Search for other papers by Michel Velten in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Enora Clero in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Stéphane Maillard in
Google Scholar
PubMed
Search for other papers by Emilie Marrer in
Google Scholar
PubMed
Search for other papers by Laurent Bailly in
Google Scholar
PubMed
Search for other papers by Eugènia Mariné Barjoan in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Jacques Orgiazzi in
Google Scholar
PubMed
Université Paris-Saclay, Villejuif, France
Search for other papers by Elisabeth Adjadj in
Google Scholar
PubMed
Search for other papers by Celia M. Pereda in
Google Scholar
PubMed
Search for other papers by Silvia Turcios in
Google Scholar
PubMed
Search for other papers by Milagros Velasco in
Google Scholar
PubMed
Search for other papers by Mae Chappe in
Google Scholar
PubMed
Search for other papers by Idalmis Infante in
Google Scholar
PubMed
Search for other papers by Marlene Bustillo in
Google Scholar
PubMed
Search for other papers by Anabel García in
Google Scholar
PubMed
Search for other papers by Sirced Salazar in
Google Scholar
PubMed
Search for other papers by Regla Rodriguez in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Mohamed Amine Benadjaoud in
Google Scholar
PubMed
Search for other papers by Rosa M. Ortiz in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Carole Rubino in
Google Scholar
PubMed
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France
Search for other papers by Florent de Vathaire in
Google Scholar
PubMed
Introduction Over the last few decades, the differentiated thyroid cancer (DTC) incidence has grown rapidly in many countries [ 1 ]. The study of DTC risk factors is therefore of great importance to understand this observed increase in
Search for other papers by Alexis Lacout in
Google Scholar
PubMed
Search for other papers by Emmanuel Chamorey in
Google Scholar
PubMed
Search for other papers by Juliette Thariat in
Google Scholar
PubMed
Search for other papers by Mostafa El Hajjam in
Google Scholar
PubMed
Search for other papers by Carole Chevenet in
Google Scholar
PubMed
Search for other papers by Renaud Schiappa in
Google Scholar
PubMed
Search for other papers by Pierre Yves Marcy in
Google Scholar
PubMed
,000 inhabitants in France [ 1 ]. Thyroid cancer-related mortality yields 0.3 per 100,000 inhabitants per year, i.e., leading to almost 400 deaths per year [ 1 ]. Well-differentiated thyroid carcinomas (DTC) (90%), including papillary thyroid carcinoma (PTC) and
Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Search for other papers by Saima Riaz in
Google Scholar
PubMed
Search for other papers by Humayun Bashir in
Google Scholar
PubMed
Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Search for other papers by Raza Hussain in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) is typically indolent if treated early and appropriately. A small subset of more aggressive disease progresses to radioiodine resistance. Based on the American Thyroid Association (ATA) risk of
Search for other papers by Mario Rotondi in
Google Scholar
PubMed
Search for other papers by Maria Grazia Castagna in
Google Scholar
PubMed
Search for other papers by Carlo Cappelli in
Google Scholar
PubMed
Search for other papers by Cristina Ciuoli in
Google Scholar
PubMed
Search for other papers by Francesca Coperchini in
Google Scholar
PubMed
Search for other papers by Francesco Chiofalo in
Google Scholar
PubMed
Search for other papers by Fabio Maino in
Google Scholar
PubMed
Search for other papers by Paola Palmitesta in
Google Scholar
PubMed
Search for other papers by Luca Chiovato in
Google Scholar
PubMed
Search for other papers by Furio Pacini in
Google Scholar
PubMed
thyroid cancer incidence, 1973-2002. Cancer Causes Control 2009;20:525-531. 10.1007/s10552-008-9260-4 19016336 2 Chen AY, Jemal A, Ward EM: Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009
Search for other papers by Samuel Chan in
Google Scholar
PubMed
Search for other papers by Katarina Karamali in
Google Scholar
PubMed
Search for other papers by Anna Kolodziejczyk in
Google Scholar
PubMed
Search for other papers by Georgios Oikonomou in
Google Scholar
PubMed
Search for other papers by John Watkinson in
Google Scholar
PubMed
Search for other papers by Vinidh Paleri in
Google Scholar
PubMed
Search for other papers by Iain Nixon in
Google Scholar
PubMed
Search for other papers by Dae Kim in
Google Scholar
PubMed
Introduction The incidence of well-differentiated thyroid cancer (DTC) is increasing faster than any other malignancies and estimated to increase by 30% by 2022 [ 1 ]. Most new cases are less than 4-cm tumours (T1–2), often diagnosed early due
Search for other papers by Germán A. Jimenez Londoño in
Google Scholar
PubMed
Search for other papers by Ana Maria Garcia Vicente in
Google Scholar
PubMed
Search for other papers by Julia Sastre Marcos in
Google Scholar
PubMed
Search for other papers by Francisco Jose Pena Pardo in
Google Scholar
PubMed
Search for other papers by Mariano Amo-Salas in
Google Scholar
PubMed
Search for other papers by Manuel Moreno Caballero in
Google Scholar
PubMed
Search for other papers by Maria Prado Talavera Rubio in
Google Scholar
PubMed
Search for other papers by Beatriz Gonzalez Garcia in
Google Scholar
PubMed
Search for other papers by Niletys Dafne Disotuar Ruiz in
Google Scholar
PubMed
Search for other papers by Angel Maria Soriano Castrejón in
Google Scholar
PubMed
Introduction The incidence of thyroid cancer has increased in many countries during the past decade and this is due mainly to an improvement achieved in detection methods [ 1 , 2 ]. Most cases are of the differentiated thyroid carcinoma and
Search for other papers by Kirsten E. Stewart in
Google Scholar
PubMed
Search for other papers by Mark W.J. Strachan in
Google Scholar
PubMed
Search for other papers by Devraj Srinivasan in
Google Scholar
PubMed
Search for other papers by Morna MacNeill in
Google Scholar
PubMed
Search for other papers by Lucy Wall in
Google Scholar
PubMed
Search for other papers by Iain J. Nixon in
Google Scholar
PubMed
deemed unsuitable for surgery, limited alternative options were available. Sorafenib and lenvatinib both showed a prolonged progression-free survival advantage in patients with radioactive iodine-refractory differentiated thyroid cancer (DTC
Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Joachim N Nilsson in
Google Scholar
PubMed
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Jonathan Siikanen in
Google Scholar
PubMed
Search for other papers by Vincenzo Condello in
Google Scholar
PubMed
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Kenbugul Jatta in
Google Scholar
PubMed
Search for other papers by Ravi Saini in
Google Scholar
PubMed
Stockholms Sjukhem Foundation's Research and Development Department, Stockholm, Sweden
Department of Clinical Sciences Lund, Lund University, Lund, Sweden
Search for other papers by Christel Hedman in
Google Scholar
PubMed
Department of Breast, Endocrine Tumours and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Catharina Ihre Lundgren in
Google Scholar
PubMed
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer is treated with surgery, and in cases of larger tumours or cervical lymph node metastases, additional hormone suppression and radioiodine therapy are given. Successful radioiodine therapy requires